After bluebird bio acknowledged troubles keeping its business operational, the gene therapy biotech is launching a restructuring that will reduce the size of its workforce by about 25%.
https://www.fiercepharma.com/pharma/bluebird-bio-lays-25-workforce-gene-therapy-pioneer-struggles-stay-afloat